☆ 4.7 Letter

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Get Full Text
Add to Collection

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 133, Issue 3, Pages 921-+

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2013.11.026

Keywords

-

Categories

Allergy Immunology

Funding

  1. National Institute for Health Research [NF-SI-0512-10030, NF-SI-0510-10157, CL-2012-11-002] Funding Source: researchfish

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.